Cannabis stocks are rebounding as companies like Tilray, Canopy Growth, and Curaleaf gain momentum amid federal policy shifts and growing U.

Medicare is stepping into the cannabis conversation, exploring coverage for CBD and low-THC treatments. As federal healthcare begins to reco

Premium cannabis is entering a new era. From market crackdowns to price compression and rising demand for trust, 2026 is redefining the indu

A major study finds cannabis may not effectively treat anxiety, depression, or PTSD—and could even worsen mental health outcomes. Here’s wha